1,057 followers
A new individualized risk prediction model estimates two-year progression-free survival for adults with early-stage classic Hodgkin's lymphoma, supporting more personalized treatment planning. doi.org/g9qxks
An Individualized Prediction Model for Early-Stage Classic Hodgkin Lymphoma
Overview of attention for article published in NEJM Evidence, June 2025
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (98th percentile)
-
High Attention Score compared to outputs of the same age and source (82nd percentile)
Readers on
- mendeley
- 5 Mendeley